CircFLNA Acts as a Sponge of miR-646 to Facilitate the Proliferation, Metastasis, Glycolysis, and Apoptosis Inhibition of Gastric Cancer by Targeting PFKFB2

References

• Molina-Castro S, Pereira-Marques J, Figueiredo C, Machado JC, Varon C. Gastric cancer: basic aspects. Helicobacter. 2017;22(Suppl):1. doi:10.1111/hel.12412
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016;22(8):2403–2414. doi:10.3748/wjg.v22.i8.240326937129
   PubMed Web of Science ®Google Scholar
• Lee SY, Oh SC. Changing strategies for target therapy in gastric cancer. World J Gastroenterol. 2016;22(3):1179–1189. doi:10.3748/wjg.v22.i3.117926811656
   PubMed Web of Science ®Google Scholar
• Pellino A, Riello E, Nappo F, et al. Targeted therapies in metastatic gastric cancer: current knowledge and future perspectives. World J Gastroenterol. 2019;25(38):5773–5788. doi:10.3748/wjg.v25.i38.577331636471
   PubMed Web of Science ®Google Scholar
• Yuan LW, Yamashita H, Seto Y. Glucose metabolism in gastric cancer: the cutting-edge. World J Gastroenterol. 2016;22(6):2046–2059. doi:10.3748/wjg.v22.i6.204626877609
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Z, Wang J, et al. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review. Onco Targets Ther. 2019;12:1195–1204. doi:10.2147/OTT.S18968730863087
   PubMed Web of Science ®Google Scholar
• Li X, Yang L, Chen LL, Biogenesis T. Functions, and Challenges of Circular RNAs. Mol Cell. 2018;71(3):428–442. doi:10.1016/j.molcel.2018.06.03430057200
   PubMed Web of Science ®Google Scholar
• Tang Q, Hann SS. Biological Roles and Mechanisms of Circular RNA in Human Cancers. Onco Targets Ther. 2020;13:2067–2092. doi:10.2147/OTT.S23367232210574
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs Act as miRNA Sponges. Adv Exp Med Biol. 2018;1087:67–79. doi:10.1007/978-981-13-1426-1_630259358
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Veno MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.36128991235
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, Ge S. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6. doi:10.1186/s12943-018-0934-630626395
   PubMed Web of Science ®Google Scholar
• Xu G, Chen Y, Fu M, et al. Circular RNA CCDC66 promotes gastric cancer progression by regulating c-Myc and TGF-beta signaling pathways. J Cancer. 2020;11(10):2759–2768. doi:10.7150/jca.3771832226494
   PubMed Web of Science ®Google Scholar
• Lu J, Wang YH, Huang XY, et al. circ-CEP85L suppresses the proliferation and invasion of gastric cancer by regulating NFKBIA expression via miR-942-5p. J Cell Physiol. 2020. doi:10.1002/jcp.29556
   Web of Science ®Google Scholar
• Wang N, Lu K, Qu H, et al. CircRBM33 regulates IL-6 to promote gastric cancer progression through targeting miR-149. Biomed Pharmacother. 2020;125:109876. doi:10.1016/j.biopha.2020.10987632044717
   PubMed Web of Science ®Google Scholar
• Jiang F, Hong F, Shah MW, Shen X. Circular RNAs as diagnostic biomarkers in gastric cancer: A meta-analysis review. Pathol Res Pract. 2019;215(6):152419. doi:10.1016/j.prp.2019.04.01131043351
   PubMed Web of Science ®Google Scholar
• Lei B, Tian Z, Fan W, Ni B. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int J Med Sci. 2019;16(2):292–301. doi:10.7150/ijms.2804730745810
   PubMed Web of Science ®Google Scholar
• Hu K, Qin X, Shao Y, Zhou Y, Ye G, Circular XS. RNA MTO1 suppresses tumorigenesis of gastric carcinoma by sponging miR-3200-5p and targeting PEBP1. Mol Cell Probes. 2020;52:101562. doi:10.1016/j.mcp.2020.10156232194149
   PubMed Web of Science ®Google Scholar
• Ma Y, Cong X, Zhang Y, Yin X, Zhu Z, Xue Y. CircPIP5K1A facilitates gastric cancer progression via miR-376c-3p/ZNF146 axis. Cancer Cell Int. 2020;20(1):81. doi:10.1186/s12935-020-1122-532190005
   PubMed Web of Science ®Google Scholar
• Wang JX, Liu Y, Jia XJ, et al. Upregulation of circFLNA contributes to laryngeal squamous cell carcinoma migration by circFLNA-miR-486-3p-FLNA axis. Cancer Cell Int. 2019;19(1):196. doi:10.1186/s12935-019-0924-931384171
   PubMedGoogle Scholar
• Dai H, Hou K, Cai Z, Zhou Q, Zhu S. Low-level miR-646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression.. Oncol Lett. 2017;14(6):6708–6714. doi:10.3892/ol.2017.703229391877
   PubMed Web of Science ®Google Scholar
• Pan H, Tang L, Jiang H, et al. Enhanced expression of circ_0000267 in hepatocellular carcinoma indicates poor prognosis and facilitates cell progression by sponging miR-646. J Cell Biochem. 2019;120(7):11350–11357. doi:10.1002/jcb.28411
   PubMed Web of Science ®Google Scholar
• Zang Y, Li J, Wan B, Tai Y. circRNA circ-CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR-646. J Cell Mol Med. 2020;24(4):2423–2433. doi:10.1111/jcmm.1492531951319
   PubMed Web of Science ®Google Scholar
• Zhang P, Tang WM, Zhang H, et al. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer. Br J Cancer. 2017;117(4):525–534. doi:10.1038/bjc.2017.18128632723
   PubMed Web of Science ®Google Scholar
• Xue M, Li G, Fang X, Wang L, Jin Y, Zhou Q. hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway. Cancer Cell Int. 2019;19(1):25. doi:10.1186/s12935-019-0737-x30733646
   PubMedGoogle Scholar
• Tang N, Zhang J, Fu X, Xie W, Qiu Y. PP2Acalpha inhibits PFKFB2-induced glycolysis to promote termination of liver regeneration. Biochem Biophys Res Commun. 2020. doi:10.1016/j.bbrc.2020.03.002
   Web of Science ®Google Scholar
• Moon JS, Jin WJ, Kwak JH, et al. Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells. Biochem J. 2011;433(1):225–233. doi:10.1042/BJ2010110420958264
   PubMedGoogle Scholar
• He Z, You C, Zhao D. Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells. Biochem Biophys Res Commun. 2018;500(3):569–576. doi:10.1016/j.bbrc.2018.04.09129655792
   PubMed Web of Science ®Google Scholar
• Zhao L, Ji G, Le X, et al. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer. Cancer Res. 2017;77(6):1369–1382. doi:10.1158/0008-5472.CAN-16-161528087599
   PubMed Web of Science ®Google Scholar